In cancer EFHD2 has been associated with tumour invasion thus showing a potential interest as therapeutic target [14, 23–25] but the molecular mechanisms at the basis of these observations are less known than those related to TKS4 and TKS5. This evidence concerns the gene SH3PXD2A and neoplasm.